How does long COVID affect sleep?

How Long COVID Affects Sleep

Long COVID significantly disrupts sleep through multiple mechanisms, causing both poor sleep quality and unrefreshing sleep as core features, with bidirectional relationships where pre-existing sleep problems increase long COVID risk and long COVID subsequently worsens sleep disturbances that can persist beyond 12 months.

Sleep as Both Risk Factor and Consequence

The relationship between sleep and long COVID operates in both directions 1, 2:

Pre-infection sleep quality predicts long COVID risk:

• Poor sleep quality before SARS-CoV-2 infection increases long COVID odds by 37-94% depending on severity (medium quality: OR 1.37; low quality: OR 1.94) 1
• Greater variability in pre-infection sleep efficiency associates with higher long COVID risk (OR 1.07 per percentage-point increase) 1
• Extreme morning chronotype consistently predicts long COVID symptoms across all models 2
• Sleep deterioration during pandemic peaks compounds this risk 2

Post-infection sleep changes:

• Sleep duration increases by approximately 0.11 hours in the first month after infection, with larger increases correlating to infection severity 1
• Most non-hospitalized cases return to baseline sleep duration after 1 month 1
• However, those developing long COVID experience fluctuations in sleep duration lasting up to 6 months 1

Specific Sleep Disturbances in Long COVID

Primary Sleep Problems

Unrefreshing sleep is a cardinal feature of long COVID, particularly in those meeting ME/CFS criteria 3. The evidence shows:

• Difficulty initiating sleep increases from 31% pre-infection to 39% post-infection (P=0.01) 4
• Difficulty maintaining sleep increases more dramatically from 43% to 57% (P<0.001) 4
• Sleep aid use increases from 24% to 30% (P=0.003) 4
• Feeling rested decreases from 58% to 36% (P<0.0001) 4
• Need for napping increases from 27% to 40% (P<0.0001) 4

Prevalence and Duration

Sleep problems affect approximately 41% of long COVID patients 5. Critically, 28% of participants report persistent sleep symptoms beyond 12 months after initial infection 4, indicating this is not a transient phenomenon.

Mechanistic Pathways

Inflammatory Resolution Dysfunction

Sleep disturbance in long COVID directly impairs inflammatory resolution 6:

• Patients with high sleep disturbance (PROMIS T-score ≥60) show significantly lower levels of specialized pro-resolving mediators (SPMs)
• Specifically reduced: 17-HDHA, 17R/S-RvD1, 15R-LXB4, and PD1n-3 DPA (P<0.05)
• Pro-inflammatory pathways remain upregulated, with elevated PGE2 levels
• This creates a vicious cycle where sleep disturbance promotes chronic unresolved inflammation

Neurological Mechanisms

The comprehensive guideline evidence 3 reveals multiple neurological pathways:

• Brainstem hypometabolism correlates with specific symptoms
• Neuroinflammation with microglial reactivity similar to "chemo-brain"
• Autonomic dysfunction affecting sleep-wake regulation
• Low cortisol levels indicating hypothalamus-pituitary-adrenal axis dysfunction 3
• Brain structure changes including grey matter reduction in areas connected to sleep regulation

Clinical Associations

Individuals with sleep problems show significantly higher prevalence ratios for multiple long COVID symptoms 5:

• Altered sensitivity: PR 3.27 (95% CI 1.96-5.45)
• Nasal congestion: PR 2.75 (95% CI 1.53-4.94)
• Musculoskeletal symptoms: PR 1.75 (95% CI 1.48-2.06)
• Respiratory issues: PR 1.58 (95% CI 1.24-2.01)
• One or more long COVID symptom: PR 1.27 (95% CI 1.15-1.39)

Overlap with ME/CFS

Unrefreshing sleep is one of the diagnostic criteria for ME/CFS 3, which develops in a substantial proportion of long COVID patients. The guideline emphasizes that up to 75% of ME/CFS patients cannot work full-time, and 25% are bed-bound, highlighting the severity of this overlap.

Clinical Implications

Assessment Priorities

When evaluating long COVID patients:

• Quantify sleep disturbance using validated tools (PROMIS Sleep Disturbance scale recommended)
• Assess pre-infection sleep history to understand baseline and trajectory
• Screen for ME/CFS criteria, particularly unrefreshing sleep combined with post-exertional malaise
• Evaluate autonomic dysfunction which commonly coexists with sleep problems
• Document chronotype as extreme morning preference carries higher risk

Common Pitfalls

• Do not dismiss modest sleep duration changes as clinically insignificant—quality matters more than quantity 1
• Recognize that sleep problems may persist well beyond typical acute illness recovery (>12 months) 4
• Understand the inflammatory connection—sleep disturbance is not merely symptomatic but mechanistically drives ongoing inflammation 6
• Avoid attributing sleep problems solely to anxiety/depression—neurological and inflammatory mechanisms are primary 3

Treatment Considerations

The recent clinical practice guideline 7 provides limited specific recommendations for sleep in long COVID, suggesting:

• Cognitive behavioral therapy for patients with fatigue (which often overlaps with sleep disturbance)
• Personalized rehabilitation after excluding post-exertional malaise
• Multi-species probiotics may have indirect benefits through inflammatory modulation

Critical caveat: The guideline explicitly recommends against glucocorticoids for long COVID treatment 7, despite their potential short-term sleep benefits, due to overall risk-benefit considerations.

The evidence strongly suggests that addressing sleep disturbance should be a priority in long COVID management, as it both predicts worse outcomes and perpetuates inflammatory dysfunction when left untreated 2, 6.